Immobilized Human Activin A, No Tag at 5 μg/ml(100 μI/well) on the plate. Dose response curve for Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus, mFc Tag with the EC50 of 21.3ng/ml determined by ELISA.

Immobilized Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus, mFc Tag at 0.5 μg/ml (100 μI/well) on the plate. Dose response curve for Anti-Activin RIIB Antibody, hFc Tag with the EC50 of 6.9ng/ml determined by ELISA.

Immobilized Human/Mouse/Rat GDF-8, No Tag at 1 μg/ml (100 μI/well) on the plate. Dose response curve for Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus, mFc Tag with the EC50 of 20.8ng/ml determined by ELISA.

Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus

ActRIIB (activin receptor type-2B) is an activin receptor subtype constitutively expressed in the whole body, playing a role in cellular proliferation, differentiation, and metabolism. For its various physiological activities, ActRIIB interacts with activin and multiple other ligands including myostatin (MSTN), growth differentiation factor 11 (GDF11), and bone morphogenetic protein 9 (BMP9).

Cat. No.	Z04989
Size	100 μg : Quote 500 μg : Quote Buy in bulk
Quantity
TAT
Price	¥35,443.00


Ask us a question

Product Introduction

Species

Human/Cynomolgus

Protein Construction

Activin RIIB/ACVR2B [Ser19-Thr137 (Human) / Ser40-Thr158 (Cynomolgus)] Accession # Q13705-1 (Human) / XP_045242398.1 (Cynomolgus)	mFc (IgG1)
N-term	C-term

Purity

> 95% as determined by BisTris PAGE

Endotoxin Level

Less than 1EU per μg by the LAL method.

Biological Activity

Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.

Expression System

HEK293

Theoretical Molecular Weight

39.32 kDa

Apparent Molecular Weight

Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).

Reconstitution

Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.

Storage & Stability

Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples

Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Background

Target Background	ActRIIB (activin receptor type-2B) is an activin receptor subtype constitutively expressed in the whole body, playing a role in cellular proliferation, differentiation, and metabolism. For its various physiological activities, ActRIIB interacts with activin and multiple other ligands including myostatin (MSTN), growth differentiation factor 11 (GDF11), and bone morphogenetic protein 9 (BMP9).
Synonyms	Activin receptor type-2B; ACVR2B; Activin RIIB

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

Activin RIIB/ACVR2B mFc Chimera, Human/Cynomolgus

サポート

会社情報

サポート

会社情報